133 related articles for article (PubMed ID: 20350281)
1. Therapeutic drug monitoring in highly active antiretroviral therapy.
Liu X; Ma Q; Zhang F
Expert Opin Drug Saf; 2010 Sep; 9(5):743-58. PubMed ID: 20350281
[TBL] [Abstract][Full Text] [Related]
2. [National consensus document by GESIDA/National Aids Plan on antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2011 update)].
Panel de expertos de GESIDA y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2011 Mar; 29(3):209.e1-103. PubMed ID: 21388714
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic drug monitoring and the inhibitory quotient of antiretroviral drugs: can they be applied to the current situation?
Ribera E; López-Cortés LF; Soriano V; Casado JL; Mallolas J
Enferm Infecc Microbiol Clin; 2005 Jul; 23 Suppl 2():41-67. PubMed ID: 16373004
[TBL] [Abstract][Full Text] [Related]
4. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
Panel de expertos de Gesida y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
[TBL] [Abstract][Full Text] [Related]
5. [Utility of atazanavir in special populations].
Antela López A
Enferm Infecc Microbiol Clin; 2008 Dec; 26 Suppl 17():49-54. PubMed ID: 20116618
[TBL] [Abstract][Full Text] [Related]
6. Clinical benefit of interventions driven by therapeutic drug monitoring.
Rendón A; Núñez M; Jiménez-Nácher I; González de Requena D; González-Lahoz J; Soriano V
HIV Med; 2005 Sep; 6(5):360-5. PubMed ID: 16156885
[TBL] [Abstract][Full Text] [Related]
7. Protease inhibitor plasma concentrations in HIV antiretroviral therapy.
Justesen US
Dan Med Bull; 2008 Nov; 55(4):165-85. PubMed ID: 19232158
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of chronic hepatitis C in patients with HIV coinfection: efficacy and tolerance].
Pol S
Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B264-73. PubMed ID: 12180300
[No Abstract] [Full Text] [Related]
9. Therapeutic drug monitoring and human immunodeficiency virus (HIV) antiretroviral therapy.
Justesen US
Basic Clin Pharmacol Toxicol; 2006 Jan; 98(1):20-31. PubMed ID: 16433887
[TBL] [Abstract][Full Text] [Related]
10. Pediatric antiretroviral therapy.
Cadilla A; Qureshi N; Johnson DC
Expert Rev Anti Infect Ther; 2010 Dec; 8(12):1381-402. PubMed ID: 21133664
[TBL] [Abstract][Full Text] [Related]
11. The impact of gender and pregnancy on antiretroviral therapy for HIV: pharmacokinetic and disease-related differences.
Scarsi KK; Postelnick MJ
J Gend Specif Med; 2003; 6(1):7-16. PubMed ID: 12661172
[No Abstract] [Full Text] [Related]
12. API consensus guidelines for use of antiretroviral therapy in adults (API-ART guidelines). Endorsed by the AIDS Society of India.
Gupta SB; Pujari SN; Joshi SR; Patel AK;
J Assoc Physicians India; 2006 Jan; 54():57-74. PubMed ID: 16649742
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic drug monitoring of antiretroviral agents scenario.
Moltó J; Clotet B
J HIV Ther; 2004 Nov; 9(4):75-8. PubMed ID: 15731738
[TBL] [Abstract][Full Text] [Related]
14. A prospective controlled study of neurodevelopment in HIV-uninfected children exposed to combination antiretroviral drugs in pregnancy.
Alimenti A; Forbes JC; Oberlander TF; Money DM; Grunau RE; Papsdorf MP; Maan E; Cole LJ; Burdge DR
Pediatrics; 2006 Oct; 118(4):e1139-45. PubMed ID: 16940166
[TBL] [Abstract][Full Text] [Related]
15. [Immunosuppressive drugs and highly active antiretroviral therapy: pharmacokinetic interactions].
Moretto J; Bessard G; Stanke-Labesque F
Therapie; 2007; 62(4):327-35. PubMed ID: 17983558
[TBL] [Abstract][Full Text] [Related]
16. Optimal antiretroviral therapy: HIV-1 treatment strategies to avoid and overcome drug resistance.
Grant PM; Zolopa AR
Curr Opin Investig Drugs; 2010 Aug; 11(8):901-10. PubMed ID: 20721832
[TBL] [Abstract][Full Text] [Related]
17. [HIV, breast feeding and antiretroviral agents].
Engebretsen IM; Tylleskär T
Tidsskr Nor Laegeforen; 2010 Mar; 130(5):520-2. PubMed ID: 20224625
[No Abstract] [Full Text] [Related]
18. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
19. Obstetric and perinatal complications in HIV-infected women. Analysis of a cohort of 167 pregnancies between 1997 and 2003.
Martí C; Peña JM; Bates I; Madero R; de José I; Pallardo LF; Arribas JR; Gonzalez-Garcia J; Gonzalez A; Vazquez JJ
Acta Obstet Gynecol Scand; 2007; 86(4):409-15. PubMed ID: 17486461
[TBL] [Abstract][Full Text] [Related]
20. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].
Pozio E
Parassitologia; 2004 Jun; 46(1-2):89-93. PubMed ID: 15305694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
